Share your thoughts on our News & Insights section. Complete our survey to help us improve.

Forbes: Pfizer will charge up to $1,400 for Covid drug

Important information - This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.

Pfizer will charge health insurers as much as $1,390 for a five-day course of its Covid-19 treatment Paxlovid, the company told multiple news outlets, a price that comes as the drug's distribution changes hands from the federal government to Pfizer's commercial business—and as Pfizer predicts lower revenue from its coronavirus products.

This article is more than 6 months old

It was correct at the time of publishing. Our views and any references to tax, investment, and pension rules may have changed since then.